The Impact of Venous Stenting on Symptoms and Quality of Life in Patients with Idiopathic Intracranial Hypertension and Spontaneous Cerebrospinal Fluid Leak

Abstract

Background

Elevated intracranial pressure can cause skull base defects and a spontaneous cerebrospinal fluid (CSF) leak. Venous sinus stenting (VSS) has emerged as a promising treatment option for patients with a CSF leak in the setting of idiopathic intracranial hypertension (IIH). There is a lack of literature on symptomatology and quality of life (QOL) after VSS for IIH patients with a CSF leak. This study explores the effects of VSS on symptoms and QOL in IIH patients with a CSF leak.

Methods

This is a retrospective study on patients who have IIH complicated by a CSF leak and underwent VSS. A QOL questionnaire was developed from the migraine disability assessment test and the PROMIS-PI was given to patients included in this study.

Results

A total of 10 patients were included in this study. Nine patients underwent endoscopic closure of CSF prior to stent placement and one patient was treated with VSS only. There was no evidence of CSF leak recurrence in this population following VSS. Headaches improved in 5/8, tinnitus in 5/6, and visual disturbance in 4/5 patients. Diamox was discontinued in seven out of eight patients after VSS. There was an improvement in headache-specific questions (p = 0.0140) and overall QOL (p = 0.0061) on the QOL questionnaire.

Discussion

This preliminary study demonstrates that VSS is effective in alleviating many symptoms in IIH patients with a CSF leak, especially headaches. Diamox may be able to be discontinued in many patients following VSS. No CSF leak recurrence was noted in this patient population.

Keywords

idiopathic intracranial hypertension - spontaneous cerebrospinal fluid leak - skull base - venous sinus stenting

• References

• 1 Hurel C, Favier V, de Bonnecaze G. et al. Transverse venous sinus stenosis in patients with nasal cerebrospinal fluid leak and idiopathic intracranial hypertension. Otolaryngol Head Neck Surg 2023; 169 (06) 1647-1653
• 2 Georgalas C, Oostra A, Ahmed S. et al. International consensus statement: spontaneous cerebrospinal fluid rhinorrhea. Int Forum Allergy Rhinol 2021; 11 (04) 794-803
• 3 Iyer RR, Solomon D, Moghekar A. et al. Venous sinus stenting in the management of patients with intracranial hypertension manifesting with skull base cerebrospinal fluid leaks. World Neurosurg 2017; 106: 103-112
• 4 Labeyrie MA, Bedarida V, Vever U. et al. Venous sinus stenting after repair of skull base spontaneous cerebrospinal fluid leaks: a single-center retrospective cohort series with case-control analysis. J Neuroradiol 2022; 49 (02) 164-168
• 5 Labeyrie MA, Fantoni M, Vever U. et al. Intracranial venous sinus stenting for the treatment of lateral sinus stenoses: an analysis of 200 patients. Diagn Interv Imaging 2021; 102 (10) 619-627
• 6 Nia AM, Srinivasan VM, Lall R, Kan P. Dural venous sinus stenting in idiopathic intracranial hypertension: a national database study of 541 patients. World Neurosurg 2022; 167: e451-e455
• 7 Lenck S, Nouet A, Shotar E. et al. Transverse sinus stenting without surgical repair in idiopathic CSF rhinorrhea associated with transverse sinus stenoses: a pilot study. J Neurosurg 2021; 136 (06) 1745-1751
• 8 Tosi U, Ramos A, Rampichini M. et al. Combined surgical repair and venous sinus stenting for patients with skull base encephaloceles secondary to dural venous sinus stenosis. Acta Neurochir (Wien) 2023; 165 (08) 2283-2292
• 9 Bruce BB, Digre KB, McDermott MP, Schron EB, Wall M. NORDIC Idiopathic Intracranial Hypertension Study Group. Quality of life at 6 months in the idiopathic intracranial hypertension treatment trial. Neurology 2016; 87 (18) 1871-1877
• 10 Garner RM, Aldridge JB, Wolfe SQ, Fargen KM. Quality of life, need for retreatment, and the re-equilibration phenomenon after venous sinus stenting for idiopathic intracranial hypertension. J Neurointerv Surg 2021; 13 (01) 79-85
• 11 Carvalho GF, Luedtke K, Braun T. Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire. J Headache Pain 2021; 22 (01) 126
• 12 Daggubati LC, Liu KC. Intracranial venous sinus stenting: a review of idiopathic intracranial hypertension and expanding indications. Cureus 2019; 11 (02) e4008
• 13 King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 1995; 45 (12) 2224-2228
• 14 Lim J, Monteiro A, Kuo CC. et al. Stenting for venous sinus stenosis in patients with idiopathic intracranial hypertension: an updated systematic review and meta-analysis of the literature. Neurosurgery 2022
• 15 Gorjian M, Andrada JE, Sitko KR. et al. Dural venous sinus stenting technique for idiopathic intracranial hypertension in patients with tortuous venous anatomy. Neurosurg Rev 2023; 46 (01) 177
• 16 Fargen KM, Liu K, Garner RM, Greeneway GP, Wolfe SQ, Crowley RW. Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting. J Neurointerv Surg 2018; 10 (12) 1203-1208
• 17 Nicholson P, Brinjikji W, Radovanovic I. et al. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neurointerv Surg 2019; 11 (04) 380-385
• 18 Midtlien JP, Kittel C, Klever LA, Kiritsis NR, Aldridge JB, Fargen KM. Redefining treatment expectations: exploring mid- and long-term outcomes of venous sinus stenting in idiopathic intracranial hypertension. J Neurointerv Surg 2024; jnis-2023-021336
• 19 Drocton GT, Copelan A, Eisenmenger L. et al. Venous sinus stenting as a treatment approach in patients with idiopathic intracranial hypertension and encephaloceles. Interv Neuroradiol 2021; 27 (01) 129-136
• 20 Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain 2015; 16: 521
• 21 Kalyvas A, Neromyliotis E, Koutsarnakis C. et al. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurg Rev 2021; 44 (02) 773-792